FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly ophthalmology, and is intended for obtaining medical product for surgical treatment of eyes. Aqueous viscoelastic liquid contains hyaluronic acid in concentration 0.01 to 30 w/v %, has pH value 6 to 8.5, and has osmolarity 200 to 400 mosmole/l.
EFFECT: this liquid after application from container with single dose upon eye surface causes optical effect of increasing lens and pupil, and also provides protection of cornea from drying and epithelial damages during eye surgery.
5 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
SYNTHETIC VISCOELASTIC MATERIAL FOR OPHTHALMOLOGIC APPLICATION | 1994 |
|
RU2145882C1 |
METHOD OF PRODUCING SOLUTION AND SOLUTION FOR TREATING, PREVENTING DISEASES AND INJURIES | 2015 |
|
RU2585955C1 |
OPHTHALMIC COMPOSITIONS AND METHODS OF TREATING EYES | 2005 |
|
RU2410081C2 |
OPHTHALMOLOGIC COMPOSITION WITH AMPHOTERIC SURFACE-ACTIVE SUBSTANCE HYALURONIC ACID | 2008 |
|
RU2448736C1 |
HYALURONIC ACID COMPOSITIONS WITH HIGH-ELASTICITY AND METHODS OF USING THEREOF | 2016 |
|
RU2727809C2 |
PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND TRAMADOL FOR OPHTHALMIC APPLICATION | 2014 |
|
RU2694369C2 |
METHOD FOR SOLUTION PREPARATION AND SOLUTION FOR TREATMENT AND PREVENTION OF KERATODERMA DISEASES AND INJURIES | 2006 |
|
RU2336862C2 |
FRACTION OF HYALURONIC ACID OR ITS SALT, METHOD OF PURIFICATION OF THIS FRACTION, METHODS OF PREPARING THIS FRACTION, PHARMACEUTICAL PREPARATION AND AGENTS USED IN OPHTHALMOLOGY | 1992 |
|
RU2128666C1 |
Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
EYES TREATING APPARATUS | 1999 |
|
RU2163109C2 |
Authors
Dates
2016-11-27—Published
2012-03-05—Filed